Search - tctmd.com

Displaying 301 - 320 of 366

Sort: Relevancy | Date

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

News Daily News

Ipsilateral Ulnar Compression Significantly Reduces Risk of Radial Artery Occlusion After Transradial PCI

Michael O'Riordan

October 03, 2016

News Opinion Editor's Corner

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

Shelley Wood

August 24, 2016

News Daily News

‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed

Michael O'Riordan

August 01, 2016

News Daily News

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

Michael O'Riordan

July 27, 2016

News Daily News

PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año

Michael O'Riordan

July 27, 2016

News Daily News

PLATFORM：FFRCT 指导的策略在疑似 CAD 患者中可“坚持”到 1 年

Michael O'Riordan

July 27, 2016

Presentation CCVVC 2016

Anti-Thrombotic Therapy for PCI

Presenter: Deepak L. Bhatt

June 16, 2016

News Daily News

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Michael O'Riordan

June 14, 2016

News Conference News EuroPCR 2016

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Shelley Wood

May 18, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2016

Shelley Wood

March 30, 2016

News Daily News

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Michael O'Riordan

March 30, 2016

News Daily News

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Michael O'Riordan

March 16, 2016

News Daily News

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

Michael O'Riordan

March 14, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

How I Optimize Stent Implantation

Presenter: Jeffrey W. Moses

March 11, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

Use Imaging to Optimize and Understand BRS

Presenter: Alexandre Abizaid

March 10, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

Role of OCT in Evaluation and treatment of In Stent Restenosis

Presenter: Andrew Lituchy

March 10, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

Presenter: Ajay J. Kirtane

March 10, 2016

News Industry News

REVA Achieves Target Patient Enrollment in FANTOM II Trial

February 23, 2016

News Conference News ISET 2016

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Michael O'Riordan

February 10, 2016

Advertisement

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Ipsilateral Ulnar Compression Significantly Reduces Risk of Radial Artery Occlusion After Transradial PCI

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año

PLATFORM：FFRCT 指导的策略在疑似 CAD 患者中可“坚持”到 1 年

Anti-Thrombotic Therapy for PCI

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

TCTMD’s Top 10 Most Popular Stories for March 2016

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

How I Optimize Stent Implantation

Use Imaging to Optimize and Understand BRS

Role of OCT in Evaluation and treatment of In Stent Restenosis

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

REVA Achieves Target Patient Enrollment in FANTOM II Trial

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content